Cedillo v. Secretary of Health and Human Services


Cedillo v. Secretary of Health and Human Services is a significant case in the context of vaccine litigation in the United States. The case was part of the Omnibus Autism Proceeding (OAP), which was established to handle numerous claims that vaccines, specifically the measles, mumps, and rubella (MMR) vaccine, were linked to the development of autism in children.
Background[edit]
The case was brought by the parents of Michelle Cedillo, who claimed that the MMR vaccine caused their daughter's autism. The Cedillos argued that the vaccine led to a series of medical conditions, including autism, inflammatory bowel disease, and other health issues. The case was one of the first test cases in the OAP, which was designed to address the claims of thousands of families who believed that vaccines had caused autism in their children.
Proceedings[edit]
The case was heard by the United States Court of Federal Claims, which handles cases under the National Vaccine Injury Compensation Program (VICP). The VICP was established to provide compensation to individuals who suffer injuries or adverse effects from vaccines, while also protecting vaccine manufacturers from liability.
During the proceedings, the court examined extensive scientific evidence and expert testimony. The evidence included studies on the safety and efficacy of the MMR vaccine, as well as research on the potential link between vaccines and autism.
Decision[edit]
In 2009, the court ruled against the Cedillos, finding that they had not provided sufficient evidence to support their claim that the MMR vaccine caused Michelle Cedillo's autism. The court concluded that the scientific evidence overwhelmingly supported the safety of the MMR vaccine and found no credible evidence linking it to autism.
The decision in Cedillo v. Secretary of Health and Human Services was a significant moment in the broader debate over vaccines and autism. It reinforced the scientific consensus that vaccines do not cause autism and underscored the importance of relying on rigorous scientific evidence in legal proceedings related to public health.
Impact[edit]
The ruling in Cedillo v. Secretary of Health and Human Services, along with similar decisions in other test cases within the OAP, helped to reaffirm public confidence in the safety of vaccines. It also highlighted the role of the VICP in addressing vaccine injury claims and ensuring that individuals who are genuinely harmed by vaccines receive compensation.
The case remains a key reference point in discussions about vaccine safety, public health policy, and the legal mechanisms for addressing vaccine-related injuries.
See also[edit]
- Omnibus Autism Proceeding
- National Vaccine Injury Compensation Program
- Measles, mumps, and rubella vaccine
- Autism
- Vaccine litigation
References[edit]
External links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
